TUESDAY, Nov. 17, 2020 (HealthDay News) — Lack of insurance coverage for gender-affirming hormones is associated with a lower likelihood of hormone use and higher odds of use of nonprescription hormones among transgender adults, according to a study published in the November issue of the Annals of Family Medicine. Daphna Stroumsa, M.D., from the University...